Related Experiment Video
Updated: Aug 12, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Problems to control TB in eastern Europe and consequences in low incidence countries
1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Pneumology Department, S. Maugeri Foundation, IRCCS, Via Roncaccio 16, 21049, Tradate, Varese, Italy. gbmigliori@fsm.it
Tuberculosis (TB) rates are rising in Eastern Europe due to socio-economic factors and weak health systems, leading to the spread of drug-resistant TB. Reforms and international cooperation are crucial to control this public health emergency.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- Tuberculosis (TB) notification rates, previously declining in industrialized nations, have plateaued or increased in the USA and Europe.
- A significant divergence is observed between Central/Eastern and Western European countries regarding TB trends.
- Central and Eastern European nations, particularly former USSR states, show stagnant or rising TB rates since the 1990s.
Purpose of the Study:
- To analyze the key factors contributing to the worsening TB control in Eastern Europe.
- To examine the implications of this situation for Western European countries.
- To propose potential strategies for improved TB management in the region.
Main Methods:
- Evaluation of age-specific TB notification rates across European sub-regions.
- Analysis of socio-economic factors, health system weaknesses, and specific risk groups influencing TB control.
- Review of consequences, including the spread of drug resistance and multidrug-resistant TB (MDRTB).
Main Results:
- Eastern Europe exhibits a TB pattern affecting younger populations, indicating rampant community transmission.
- Major challenges include socio-economic crises, weak health systems, the HIV pandemic, MDRTB, and inadequate control in prisons.
- Sub-optimal TB control facilitates the exportation of TB cases and drug resistance, including MDRTB, to Western Europe via immigration.
Conclusions:
- Effective TB control is achievable, as demonstrated by successful outcomes in the Czech Republic, Slovakia, and Slovenia.
- A comprehensive health system reform, emphasizing cost-effective interventions, is essential, especially in former USSR countries.
- Prompt international action is required to manage MDRTB as an emergency, fostering collaboration between donor and recipient nations.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Toxoplasmosis